Video Interview: Tech Transfer Powered by Dual-Site Precision

Successful tech transfer begins with early alignment, clear scope definition, and proactive risk management to ensure smooth progression from development to GMP manufacturing. By combining global expertise with local execution, we deliver consistent quality, operational flexibility, and reduced risk for clients advancing complex therapies.

What to expect in this video interview

Henning Gerschewski, our VP of Manufacturing Science and Technology, and Patrick Cushing, our VP Operations, spoke with Megan Manzano of BioPharm International, about how Rentschler Biopharma leverages a highly coordinated dual site model to streamline tech transfer between sites. Central to this approach is early-stage planning, timeline alignment, and a deep understanding of process robustness. Risk mitigation, too, plays a huge role in identifying differences in equipment, scale, and processes, while defining critical parameters to enable a smooth and reliable transfer. Ultimately, strong communication, experienced project teams, and a commitment to quality and compliance allows us to accelerate timelines while delivering both efficiency and confidence to clients.

 Key Takeaways

• Understand the key elements required for a successful tech transfer.
• Evaluate how dual-site manufacturing models can enhance flexibility, scalability, and consistency in biopharmaceutical production.
• Identify strategies to accelerate tech transfer timelines while maintaining process, product quality, and regulatory compliance.